News | Ventricular Assist Devices (VAD) | September 12, 2019

CorWave Presents First Successful In Vivo 60-day Study of Neptune LVAD

Data was reported at the 46th Annual Conference of the European Society for Artificial Organs

CorWave Presents First Successful In Vivo 60-day Study of Neptune LVAD

September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its Neptune left ventricular assist device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO), Sept. 8-12 in Hannover, Germany.

Trevor Snyder, Ph.D., senior director, translational and clinical research at CorWave, delivered an oral presentation, “CorWave LVAD: A physiologic, pulsatile-flow wave membrane pump.”

CorWave previously reported on the successful completion of 30-day follow-up of an earlier in vivo study. The final results of the 60-day experience, presented at the ESAO conference, confirm the CorWave pump’s ability to provide chronic circulatory support with outstanding hemocompatibility.

The CorWave technology features a physiologic design enabled by its unique undulating membrane. Among other advantages, the membrane is able to generate a natural pulse, replicating the blood flow and pressure characteristics of the patient’s native heart. CorWave’s membrane pump technology is being developed to reduce complications associated with current devices and improve the care of patients with heart failure. 

For more information: www.corwave.com

Related Content

News | Hemodynamic Support Devices

November 12, 2020 — Abiomed recently announced new PROTECT III study data that demonstrates reduced rates of MACCE ...

Home November 12, 2020
Home
Videos | Hemodynamic Support Devices

Chuck Simonton, M.D., chief medical officer at Abiomed, discusses some of the new technologies and clinical trials the ...

Home October 20, 2020
Home
News | Hemodynamic Support Devices

October 16, 2020 — The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more ...

Home October 16, 2020
Home
News | Hemodynamic Support Devices

July 16, 2020 – The U.S. Food and Drug Administration (FDA) approved one-way digital data streaming during patient ...

Home July 16, 2020
Home
News | Hemodynamic Support Devices

June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational ...

Home June 05, 2020
Home
Videos | Hemodynamic Support Devices

This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and ...

Home June 05, 2020
Home
Videos | Hemodynamic Support Devices

Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and ...

Home February 07, 2020
Home
Videos | Hemodynamic Support Devices

Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of ...

Home January 24, 2020
Home
Videos | Hemodynamic Support Devices

Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa Smith ...

Home January 09, 2020
Home
Subscribe Now